Allgens Medical Technology CO., LTD.

SHSE:688613 Stock Report

Market Cap: CN¥2.5b

Allgens Medical Technology Past Earnings Performance

Past criteria checks 0/6

Allgens Medical Technology's earnings have been declining at an average annual rate of -19%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 2.8% per year. Allgens Medical Technology's return on equity is 0.02%, and it has net margins of 2.7%.

Key information

-19.0%

Earnings growth rate

-25.8%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate2.8%
Return on equity0.02%
Net Margin2.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

There Might Be More To Allgens Medical Technology's (SHSE:688613) Story Than Just Weak Earnings

May 02
There Might Be More To Allgens Medical Technology's (SHSE:688613) Story Than Just Weak Earnings

Recent updates

Allgens Medical Technology CO., LTD.'s (SHSE:688613) 27% Price Boost Is Out Of Tune With Earnings

Aug 16
Allgens Medical Technology CO., LTD.'s (SHSE:688613) 27% Price Boost Is Out Of Tune With Earnings

Allgens Medical Technology CO., LTD.'s (SHSE:688613) Share Price Could Signal Some Risk

Jun 06
Allgens Medical Technology CO., LTD.'s (SHSE:688613) Share Price Could Signal Some Risk

There Might Be More To Allgens Medical Technology's (SHSE:688613) Story Than Just Weak Earnings

May 02
There Might Be More To Allgens Medical Technology's (SHSE:688613) Story Than Just Weak Earnings

Revenue & Expenses Breakdown

How Allgens Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688613 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24191513539
30 Jun 242092813545
31 Mar 242264313247
31 Dec 232265412346
30 Sep 232538410944
30 Jun 23259989445
31 Mar 232471017945
31 Dec 22245957157
30 Sep 222571016456
30 Jun 222491066152
31 Mar 222451165547
31 Dec 212361215433
30 Sep 212361284726
30 Jun 212331264420
31 Mar 212061073917
31 Dec 20184894016
31 Dec 19169685422
31 Dec 18124335718
31 Dec 1791243412

Quality Earnings: 688613 has a large one-off gain of CN¥19.7M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 688613's current net profit margins (2.7%) are lower than last year (33.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688613's earnings have declined by 19% per year over the past 5 years.

Accelerating Growth: 688613's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688613 had negative earnings growth (-93.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 688613's Return on Equity (0.02%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 08:29
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Allgens Medical Technology CO., LTD. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xiao Wei LinEverbright Securities Co. Ltd.
Zhuo HuangEverbright Securities Co. Ltd.
Yuan Yuan SunIndustrial Securities Co. Ltd.